Graft failure after allogeneic hematopoietic stem cell transplantation.
Ozdemir ZN, Civriz Bozdağ S.
Transfus Apher Sci. 2018 Apr;57(2):163-167. doi: 10.1016/j.transci.2018.04.014. Epub 2018 Apr 18.
Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment.
Kreidieh F, Abou Dalle I, Moukalled N, El-Cheikh J, Brissot E, Mohty M, Bazarbachi A.
Int J Hematol. 2022 Sep;116(3):330-340. doi: 10.1007/s12185-022-03416-7. Epub 2022 Jul 16.
Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease.
van Lier YF, Vos J, Blom B, Hazenberg MD.
Gut Microbes. 2023 Jan-Dec;15(1):2178805. doi: 10.1080/19490976.2023.2178805.
Gut microbiota injury in allogeneic haematopoietic stem cell transplantation.
Shono Y, van den Brink MRM.
Nat Rev Cancer. 2018 May;18(5):283-295. doi: 10.1038/nrc.2018.10. Epub 2018 Feb 16.
Management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplants.
Allaw F, Haddad SF, Zakhour J, Kanj SS.
Int J Antimicrob Agents. 2023 Aug;62(2):106860. doi: 10.1016/j.ijantimicag.2023.106860. Epub 2023 May 21.
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy.
Sauerer T, Velázquez GF, Schmid C.
Mol Cancer. 2023 Nov 11;22(1):180. doi: 10.1186/s12943-023-01889-6.
Haematopoietic stem cell transplants: principles and indications.
Balassa K, Danby R, Rocha V.
Br J Hosp Med (Lond). 2019 Jan 2;80(1):33-39. doi: 10.12968/hmed.2019.80.1.33.
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Giralt S, Gutman J, Ho V, Horwitz M, Hsu J, Juckett M, Kharfan-Dabaja MA, Loren A, Meade J, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Roddy J, Satyanarayana G, Schroeder M, Tan CR, Tzachanis D, Burn J, Pluchino L.
J Natl Compr Canc Netw. 2020 May 1;18(5):599-634. doi: 10.6004/jnccn.2020.0021.
T-Cell Progenitors As A New Immunotherapy to Bypass Hurdles of Allogeneic Hematopoietic Stem Cell Transplantation.
Gaudeaux P, Moirangthem RD, Bauquet A, Simons L, Joshi A, Cavazzana M, Nègre O, Soheili S, André I.
Front Immunol. 2022 Jul 7;13:956919. doi: 10.3389/fimmu.2022.956919. eCollection 2022.
Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation.
Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B.
Biol Blood Marrow Transplant. 2017 Mar;23(3):388-397. doi: 10.1016/j.bbmt.2016.12.632. Epub 2016 Dec 27.
